TSS Welcomes Thomas Lindén as New Chief Technology Officer

TSS logo.
TSS, a leading temperature monitoring solutions provider, is pleased to announce the appointment of Thomas Lindén as its new Chief Technology Officer (CTO). In this role, Thomas Lindén will play a crucial part in shaping the company's technological landscape and driving its growth strategies.
PRESS RELEASE 12 September 2023

Thomas Lindén brings with him a wealth of experience and expertise. He holds a Master of Science degree in Systems, Control, and Robotics from the prestigious KTH Royal Institute of Technology. Recently serving as the Vice President of Engineering at Solidsport, a SaaS sports streaming platform, he has demonstrated exceptional leadership in guiding the company's technical endeavours.

His previous role at Solidsport involved overseeing the engineering division, where he played a pivotal role in preparing the technology organization for a successful European expansion. This endeavour encompassed a strategic focus on technical solutions, talent acquisition, process enhancement, and establishing effective routines. Furthermore, Thomas Lindén has served as Interim CEO of Solidsport, highlighting his multifaceted leadership capabilities.

Prior to his tenure at Solidsport, Thomas spent over a decade in the defense industry, contributing extensively to the development of safety-critical and mission-critical systems at Saab. He held key positions, leading software projects and eventually ascending to the role of Section Manager for Electronic Warfare software platform to Gripen E/F at first, and later on the Combat System software platform to naval ships, including e.g. the Visby-class Corvette and A26. Furthermore, he spearheaded the introduction of a collaborative software supply chain in collaboration with Ericsson, a testament to his prowess in driving strategic partnerships.

Commenting on his new role, Thomas Lindén expressed enthusiasm about contributing to TSS's strategic tech agenda. He emphasized the importance of cohesive teamwork as a fundamental pillar of success and looks forward to his new endeavours at TSS.

The Chief Executive Officer (CEO) of TSS, Dr. Niclas Ohlsson, lauded Thomas's impressive track record and visionary leadership. Dr. Niclas Ohlsson explained, "Thomas Lindén's remarkable journey in technology leadership, coupled with his strategic acumen, makes him the ideal choice to lead TSS's technological advancements. We are confident that his expertise will further propel TSS towards achieving our business goals."

TSS eagerly anticipates the innovative and transformative contributions that Thomas Lindén will bring to the company in his capacity as Chief Technology Officer. His appointment signals a new era of technological innovation and strategic growth for TSS.

Thomas Lindén, Chief Technology Officer, TSS
Thomas Lindén, Chief Technology Officer, TSS

About TSS

TSS is a temperature monitoring and supply chain solutions provider serving the life science and pharmaceutical industry globally. With headquarters in Sweden, TSS have 30 years of experience providing a compliance baseline in hosting GxP Data and GxP validated SaaS to life science companies.

TSS aims to assure safe drugs for every patient by transforming the global pharmaceutical supply chain through an industry leading cloud temperature management solutions. Working in partnership with pharmaceutical companies, TSS provide advanced monitoring and analytics tools to help our client's meet compliance, implement lean and sustainable supply chains, and deliver drugs safely.

Contact

Niclas Ohlsson, PhD
Chief Executive Officer, TSS
niclas.ohlsson@tss.se

For media inquiries:

Josefin Malmgren
Head of Marketing, TSS
josefin.malmgren@tss.se

You may also be interested in

Event banner for Clinical Trial Supply Europe 2023 in Milan, Italy.

Join us at Clinical Trial Supply Europe 2023

We are glad to announce that we’re exhibiting at the next Clinical Trial Supply Europe conference organized by Arena International.
Read moreDownload Whitepaper

What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?

The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read moreDownload Whitepaper
A pharmacist ensuring product quality and compliance at a clinical site.

Enhancing Product Quality and Compliance at Clinical Sites

In the pharmaceutical industry, maintaining precise temperature monitoring is paramount to ensuring product quality and compliance with regulatory standards. The integrity of pharmaceutical products is heavily reliant on storage conditions, with deviations in temperature potentially compromising their efficacy and safety.
Read moreDownload Whitepaper

You may also be interested in

Join Us at Clinical Trial Supply East Coast US

TSS is proud to sponsor Clinical Trial Supply East Coast 2026, on November 4–5 in King of Prussia, Pennsylvania, US.
Read more

How To Minimise the Environmental Impact of Cloud Operations

When people think about sustainability transitions in pharmaceutical supply chains, they often focus on reducing product waste, or optimising transportation. These are both important initiatives, but there's another part of the equation that often goes unnoticed: the digital infrastructure powering modern supply chains.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.